Laichun Lu Selected Research

poly(N- vinylpyrrolidone)- b- poly(epsilon- caprolactone)

9/2021

Multifunctional Zinc Oxide/Silver Bimetallic Nanomaterial-Loaded Nanofibers for Enhanced Tissue Regeneration and Wound Healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laichun Lu Research Topics

Disease

3	Wounds and Injuries (Trauma) 09/2021 - 01/2013
3	Neoplasms (Cancer) 01/2018 - 10/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Nutrition Disorders (Nutritional Disorders) 01/2021
1	Melanoma (Melanoma, Malignant) 11/2017
1	Endophthalmitis (Ophthalmia) 01/2016
1	Clostridium Infections 01/2015
1	Thrombocytopenia (Thrombopenia) 11/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014
1	Vomiting 11/2014
1	Anemia 11/2014
1	Adenocarcinoma 11/2014
1	Neutropenia 11/2014

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2021 - 11/2017
2	Vancomycin FDA LinkGeneric 01/2016 - 01/2015
2	Moxifloxacin (Avelox)FDA Link 01/2016 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 01/2016
1	Caspase 6IBA 11/2021
1	yunnan baiyaoIBA 09/2021
1	poly(N- vinylpyrrolidone)- b- poly(epsilon- caprolactone)IBA 09/2021
1	borrelidinIBA 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2017
1	6-O-palmitoylascorbic acid (ascorbyl palmitate)IBA 11/2017
1	Lipid NanoparticlesIBA 11/2017
1	Docetaxel (Taxotere)FDA Link 10/2016
1	Hyaluronic Acid (Hyaluronan)IBA 10/2016
1	LigandsIBA 10/2016
1	IntegrinsIBA 10/2016
1	tetraiodothyroacetic acid (TA(4))IBA 10/2016
1	AlginatesIBA 01/2016
1	Metronidazole (Metric)FDA LinkGeneric 01/2015
1	Gemcitabine FDA Link 11/2014
1	OligosaccharidesIBA 01/2013
1	SilverIBA 01/2013
1	ChitosanIBA 01/2013

Therapy/Procedure

3	Therapeutics 11/2017 - 01/2015
1	Time-to-Treatment 11/2014